SEC Filings

S-1
AVEXIS, INC. filed this Form S-1 on 01/15/2016
Entire Document
 

 

with Executive’s work for the Company, Third Party Information unless expressly authorized by an authorized officer of the Company in writing.

 

5.5          Patient Information. Executive shall ensure that the use, retention and disclosure of individually identifiable patient information are at all times consistent with the requirements of applicable law and regulations regarding privacy.  Executive shall ensure that, if applicable, all necessary patient consents and/or authorizations have been obtained in accordance with applicable law, and nothing in this Agreement shall be construed to prohibit Executive from fully disclosing that Executive is employed by Company, where such disclosure would be appropriate under industry ethical standards or as part of professional practice.

 

5.6          Term of Nondisclosure Restrictions.  Executive understands that Confidential Information and Third Party Information are never to be used or disclosed by Executive, as provided in this Section 5.  If, however, a court decides that this Section 5 or any of its provisions is unenforceable for lack of reasonable temporal limitation and the Agreement or its restriction(s) cannot otherwise be enforced, Executive agrees and the Company agrees that the five (5) year period after the date Executive’s employment ends shall be the temporal limitation relevant to the contested restriction, provided, however, that this sentence shall not apply to trade secrets protected without temporal limitation under applicable law.

 

5.7          No Improper Use of Information of RI, Prior Employers and Others.  During Executive’s employment by the Company, he will not improperly use or disclose any confidential information, patient information or trade secrets, if any, of RI or of any former employer or any other person or entity to whom Executive has an obligation of confidentiality, and Executive will not bring onto the premises of the Company any unpublished documents or any property belonging to RI or to any former employer or any other person or entity, to whom he has an obligation of confidentiality unless consented to in writing by RI or that former employer, person or entity (as applicable), or unless otherwise directly and expressly authorized under any Research agreements between Company and RI.

 

6.             INVENTIONS AND DISCOVERIES.

 

6.1          Prior Inventions.  Inventions, if any, patented or unpatented, which Executive makes prior to the commencement of his employment with the Company (the “Prior Inventions”) are excluded from the scope of this Agreement except as otherwise expressly set forth herein.  Executive agrees that he will not incorporate, or permit to be incorporated, Prior Inventions in any Company work product or Research without the Company’s prior written consent and the written consent of the owner of such Prior Invention.

 

6.2          Inventions.  All rights in any inventions, discoveries, improvements, innovations, developments, concepts designs, research methods and results, processes, formulas, compound, works of authorship, trade secrets, know-how and creations, (patentable or not, or subject to copyright or trade secret protection), and whether or not reduced to tangible form, memorialized or reduced to practice that Executive makes, conceives or reduces to practice, either alone or jointly with others, shall reside in RI, unless otherwise specifically provided for by the terms of a sponsored research agreement.  In the event Company enters into a written agreement with RI to sponsor research conducted by Executive, RI and the Company will

 



© AveXis, Inc. All Rights Reserved.